First-in-human Study to Investigate Safety, Blood Levels and Activity of MP0274 in Cancer Patients With HER2-positive Solid Tumors
Clinical trial NCT03084926 · COMPLETED
Trial details
- NCT number
- NCT03084926
- Sponsor
- Molecular Partners AG
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-08
- Primary completion
- 2021-12-13
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.